Histone deacetylase inhibitor MS-275 alone or combined with bortezomib or sorafenib exhibits strong antiproliferative action in human cholangiocarcinoma cells (Q40088575)
Jump to navigation
Jump to search
scientific article published on September 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Histone deacetylase inhibitor MS-275 alone or combined with bortezomib or sorafenib exhibits strong antiproliferative action in human cholangiocarcinoma cells |
scientific article published on September 2007 |
Statements
1 reference
Histone deacetylase inhibitor MS-275 alone or combined with bortezomib or sorafenib exhibits strong antiproliferative action in human cholangiocarcinoma cells (English)
1 reference
Detlef Schuppan
1 reference
Viola Baradari
1 reference
Michael Höpfner
1 reference
Alexander Huether
1 reference
Hans Scherübl
1 reference
1 September 2007
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference